HALOZYME THERAPEUTICS, INC. Stock Issued
HALOZYME THERAPEUTICS, INC. (HALO) reported Stock Issued of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:StockIssued1 · last filed 2026-02-17
- HALOZYME THERAPEUTICS, INC. stock issued for the quarter ending 2024-12-31 was $0.00.
- HALOZYME THERAPEUTICS, INC. stock issued for the quarter ending 2024-09-30 was $0.00.
- HALOZYME THERAPEUTICS, INC. stock issued for the quarter ending 2024-06-30 was $0.00.
- HALOZYME THERAPEUTICS, INC. stock issued for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- HALOZYME THERAPEUTICS, INC. stock issued for fiscal 2025 was $0.00.
- HALOZYME THERAPEUTICS, INC. stock issued for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- HALOZYME THERAPEUTICS, INC. stock issued for fiscal 2023 was $125.00K, a 87.72% decline from fiscal 2022.
- HALOZYME THERAPEUTICS, INC. stock issued for fiscal 2022 was $1.02M, a 87.06% decline from fiscal 2021.
| Period end | Stock Issued 3 month | Stock Issued 6 month | Stock Issued 9 month | Stock Issued 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-17 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $0.00 derived: sum of 2 quarters · filed 2026-02-17 | $0.00 derived: sum of 3 quarters · filed 2026-02-17 | $0.00 10-K · filed 2026-02-17 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $0.00 derived: sum of 2 quarters · filed 2024-10-31 | $0.00 10-Q · filed 2024-10-31 | $0.00 derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $0.00 10-Q · filed 2024-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-02-17 | $0.00 derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-07 | $0.00 derived: sum of 2 quarters · filed 2026-02-17 | $0.00 derived: sum of 3 quarters · filed 2026-02-17 | $0.00 derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $0.00 derived: sum of 2 quarters · filed 2026-02-17 | $0.00 derived: sum of 3 quarters · filed 2026-02-17 | $125.00K 10-K · filed 2026-02-17 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $0.00 derived: sum of 2 quarters · filed 2024-10-31 | $125.00K 10-Q · filed 2024-10-31 | $124.00K derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $125.00K 10-Q · filed 2024-08-06 | $124.00K derived: sum of 3 quarters · filed 2025-02-18 | $1.14M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $125.00K 10-Q · filed 2024-05-07 | $124.00K derived: sum of 2 quarters · filed 2025-02-18 | $1.14M derived: sum of 3 quarters · filed 2025-02-18 | $1.14M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $1.02M derived: sum of 2 quarters · filed 2025-02-18 | $1.02M derived: sum of 3 quarters · filed 2025-02-18 | $1.02M 10-K · filed 2025-02-18 |
| 2022-09-30 | $1.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $1.02M derived: sum of 2 quarters · filed 2023-11-06 | $1.02M 10-Q · filed 2023-11-06 | $1.02M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | $0.00 derived: sum of 3 quarters · filed 2024-02-20 | $0.00 derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-09 | $0.00 derived: sum of 2 quarters · filed 2024-02-20 | $0.00 derived: sum of 3 quarters · filed 2024-02-20 | $0.00 derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $0.00 derived: sum of 2 quarters · filed 2024-02-20 | $0.00 derived: sum of 3 quarters · filed 2024-02-20 | $7.87M 10-K · filed 2024-02-20 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $7.87M 10-Q · filed 2022-11-08 | $7.87M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $7.87M 10-Q · filed 2022-08-09 | $7.87M derived: sum of 3 quarters · filed 2023-02-21 | $7.87M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | $7.87M 10-Q · filed 2022-05-10 | $7.87M derived: sum of 2 quarters · filed 2023-02-21 | $7.87M derived: sum of 3 quarters · filed 2023-02-21 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $0.00 derived: sum of 2 quarters · filed 2023-02-21 | $0.00 10-K · filed 2023-02-21 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $0.00 10-Q · filed 2021-11-02 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-09 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |